Steven J. Potts

BIOVIA, Inc. develops and commercializes scientific informatics software products and services for industries and organizations that rely on scientific innovation. Its enterprise platform provides a broad, flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. The company by incorporating its capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, it enables scientific innovators to access, organize, analyze and share data in various ways. BIOVIA was founded in 1993 and is headquartered in San Diego, CA.

Aperio Technologies, Inc. provided digital pathology systems and services. Its scanners created a digital image of an entire microscope slide at giga-pixel resolution in minutes, with inherently superior image quality. The company was founded in 1999 and was headquartered in Vista, CA.

Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada.

Oncomyx Therapeutics, Inc. develops and operates software platform to orchestrate an immune response and treat cancer. Its platform's features include non-human pathogen, immuno-stimulatory, ability to multi-arm, and systemic delivery. The company was founded by Steve Potts, Michael Wood, Grant McFadden and is headquartered in Phoenix, AZ.